SGLT2is are also options for monotherapy in some individuals who are not at high ASCVD risk, and as dual or triple therapy when other agents fail to control HbA1c below the individuals agreed target
Standardized diagnostic criteria and nomenclature are essential to harmonize the classification and reporting of hepatic nonproliferative as well as proliferative lesions
This evidence-based guide examines: The pharmacology and mechanism of GLP-1 receptor agonists Whether delayed gastric emptying affects nutrient absorption How sustained appetite suppression may alter micronutrient density Protein intake and lean mass preservation during rapid weight loss Nutrients of potential concern (iron, vitamin B12, folate, magnesium, calcium, vitamin D, fat-soluble vitamins, electrolytes and zinc) Clinical monitoring strategies and laboratory markers Dietary and supplementation considerations grounded in current evidence Current literature does not support the claim that GLP-1 medications universally cause micronutrient deficiencies
For example, surface-modified milk-derived exosomes exhibit improved mobility in intestinal mucus 218,219 , underscoring the potential for pulmonary therapeutic delivery
